Denali Therapeutics Inc

Common Name
Denali Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
486
Ticker
DNLI
Exchange
NASDAQ/NGS
Description
Denali Therapeutics Inc. is a biotechnology company focused on discovering and developing therapeutic interventions for neurodegenerative diseases. The primary aim of the company is to combat disorder...

Disclosures of Denali Therapeutics

Explore Denali Therapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Denali Therapeutics's official channels and fully traceable to its official company sources.

The table below lists all of Denali Therapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
10-K2024
Financial & Extra-Financial Disclosure2024
Annual Report2023
10-K2023
10-K2022
Financial & Extra-Financial Disclosure2022
10-K2021
10-K2020
10-K2019
10-K2018
10-K2017
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?